Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong tells Proactive it has been a busy and productive start to the new year with a number of presentations including at the JP Morgan Healthcare Conference. The company also presented an oral abstract and several poster sessions on its HER-Vaxx and CF33 technologies at the ASCO Gastrointestinal Cancers Symposium in the US.

Contact Details

Proactive Investors

Jonathan Jackson

+61 413 713 744